Page 38 - Pr Team News Today

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) announced a collaboration with Dr. Reddys Laboratories Limited ("Dr.

SHANGHAI, China, May 07, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) announced a collaboration with Dr. Reddy's Laboratories Limited ("Dr.

SHANGHAI, China, April 27, 2023 -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of... | April 27, 2023

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Primary Endpoint Met in RENOTORCH Study of Toripalimab for 1st-line Treatment of Advanced Renal Cell Carcinoma

Perioperative toripalimab plus chemotherapy significantly improved EFS and reduced risk of disease recurrence, progression events or death by 60% among resectable stage III NSCLC patients, compared to

Aim to propel electrification in hotter regions of the world with battery lifespan of about 9,000 cycles at 60? TOKYO, April 18, 2023 /PRNewswire/ -- 3DOM Alliance Inc. ("3DOM Alliance")

/PRNewswire/ -- 3DOM Alliance Inc. ("3DOM Alliance") today announced the development of a lithium-ion battery with the companys proprietary X-SEPA™ separator...

Jermaine Dupri, Dallas Austin and Elisabeth Omilami Among List of Honorees at the 5th Pink Awards Hosted by Carl Payne and Malik Yoba

SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Operable NSCLC Patients